Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-31 · accession 0001209191-24-000371 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2023-12-31 | WGS | Ryan Jason | Executive COB, Dir | M - OptEx | $0.00 | +67.8K | 73.6K | +1,162% | $0 |
| DM | 2024-01-03 | 2023-12-31 | WGS | Ryan Jason | Executive COB, Dir | M - OptEx | $0.00 | -67.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-31 | M | A | 67,780 | $0.00 | 73,614 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Derivative | Restricted Stock Unit | 2023-12-31 | M | D | 21,780 | $0.00 | 0 | D | — · — to — | 21,780 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances. |
| 3 | Derivative | Restricted Stock Unit | 2023-12-31 | M | D | 46,000 | $0.00 | 0 | D | — · — to — | 46,000 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances. |